Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming H Hsieh

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
Early Intervention in Psychiatry|June 22, 2018
Trajectories after first-episode psychosis: Complement to ambiguous outcomes of long-term antipsychotic treatment by exploring a few hidden casesChen-Chung Liu, Yi-Ting Lin, Chih-Min Liu, et al.
Psychoneuroendocrinology|January 7, 2015
Elevated plasma orexin A levels in a subgroup of patients with schizophrenia associated with fewer negative and disorganized symptomsYi-Ling Chien, Chih-Min Liu, Jia-Chi Shan, et al.
Psychiatry Research|May 13, 2014
A recently-discovered NMDA receptor gene, GRIN3B, is associated with duration mismatch negativityYi-Ting Lin, Ming H Hsieh, Chen-Chung Liu, et al.
Psychological Medicine|March 10, 2023
Guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis: a 2-year randomized controlled trial with a naturalistic cohortChen-Chung Liu, Ming H Hsieh, Yi-Ling Chien, et al.
Early Intervention in Psychiatry|March 22, 2021
Protocol of guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis based on pragmatic designChen-Chung Liu, Ming H Hsieh, Yi-Ling Chien, et al.
Journal of Affective Disorders|March 31, 2012
Medical costs and vasculometabolic comorbidities among patients with bipolar disorder in Taiwan - a population-based and matched-control studyMing Hong Hsieh, Chao-Hsiun Tang, Ming H Hsieh, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 14, 2023
Dose-tapering trajectories in patients with remitted psychosis undergoing guided antipsychotic reduction to reach minimum effective doseChen-Chung Liu, Ming H Hsieh, Yi-Ling Chien, et al.
Comprehensive Psychiatry|March 27, 2014
The tridimensional personality of male heroin users treated with methadone in TaiwanWei-Lieh Huang, Li-Ren Chang, Ying-Zai Chen, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 20, 2020
Clinical implications of oxidative stress in schizophrenia: Acute relapse and chronic stable phaseYi-Ling Chien, Hai-Gwo Hwu, Tzung-Jeng Hwang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 21, 2015
Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trialCharles Lung-Cheng Huang, Tzung-Jeng Hwang, Yi-Hsing Chen, et al.
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
Early Intervention in Psychiatry|June 22, 2018
Trajectories after first-episode psychosis: Complement to ambiguous outcomes of long-term antipsychotic treatment by exploring a few hidden casesChen-Chung Liu, Yi-Ting Lin, Chih-Min Liu, et al.
Psychoneuroendocrinology|January 7, 2015
Elevated plasma orexin A levels in a subgroup of patients with schizophrenia associated with fewer negative and disorganized symptomsYi-Ling Chien, Chih-Min Liu, Jia-Chi Shan, et al.
Psychiatry Research|May 13, 2014
A recently-discovered NMDA receptor gene, GRIN3B, is associated with duration mismatch negativityYi-Ting Lin, Ming H Hsieh, Chen-Chung Liu, et al.
Psychological Medicine|March 10, 2023
Guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis: a 2-year randomized controlled trial with a naturalistic cohortChen-Chung Liu, Ming H Hsieh, Yi-Ling Chien, et al.
Early Intervention in Psychiatry|March 22, 2021
Protocol of guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis based on pragmatic designChen-Chung Liu, Ming H Hsieh, Yi-Ling Chien, et al.
Journal of Affective Disorders|March 31, 2012
Medical costs and vasculometabolic comorbidities among patients with bipolar disorder in Taiwan - a population-based and matched-control studyMing Hong Hsieh, Chao-Hsiun Tang, Ming H Hsieh, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 14, 2023
Dose-tapering trajectories in patients with remitted psychosis undergoing guided antipsychotic reduction to reach minimum effective doseChen-Chung Liu, Ming H Hsieh, Yi-Ling Chien, et al.
Comprehensive Psychiatry|March 27, 2014
The tridimensional personality of male heroin users treated with methadone in TaiwanWei-Lieh Huang, Li-Ren Chang, Ying-Zai Chen, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 20, 2020
Clinical implications of oxidative stress in schizophrenia: Acute relapse and chronic stable phaseYi-Ling Chien, Hai-Gwo Hwu, Tzung-Jeng Hwang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 21, 2015
Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trialCharles Lung-Cheng Huang, Tzung-Jeng Hwang, Yi-Hsing Chen, et al.
Pageof 11